Navigating supply chains and product portfolios during a pandemic

Our managing director Brian Harrison and Enterprise Ireland USA recently had a chat about how the HiTech Health is adjusting to the new norm, and how the company is working to assure supply chain integrity in the face of a pandemic.

Read the full article here: https://bit.ly/2TPriMf

Contact HiTech Health here for more information.

Recent News

Understanding the New EU Clinical Trial Regulation (CTR)

Apr 26, 2022 | HiTech Health Latest News

On the 31st January 2022, The Clinical Trials Regulation ((Regulation (EU) No 536/2014)) became effective and replaced the previous Directive (EC) 2001/20/EC and corresponding national legislation. The Clinical Trials Regulation (CTR) coordinates the review and...

Cell and Gene Therapies: 3 Key Supply Considerations

Mar 30, 2022 | HiTech Health Latest News

Personalised medicines involve an increased degree of complexity when it comes to manufacturing and supply in comparison to traditional pharmaceuticals. The Horizon 2020 Advisory Group defines personalised medicine as 'a medical model using the characterisation of...

EMA Regulation of Cell and Gene Therapies (CGTs)

Feb 2, 2022 | HiTech Health Latest News

Cell and Gene Therapy products and other Advanced Therapy Medicinal Products (ATMPs) have to comply with European Medicines Agency (EMA) legislation at different stages of the development process, including Good clinical practice (GCP), Good manufacturing practice...